Related Experiment Video
Updated: Apr 16, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Association of FPGS genetic polymorphisms with primary retroperitoneal liposarcoma
Chengli Miao1, Ding Liu2, Feng Zhang3
11] Retroperitoneal Tumors Center, Peking University International Hospital, Beijing, P.R. China [2] Department of Surgical Oncology, Beijing Shijitan Hospital, Capital Medical University (The 9th affiliated hospital of Peking University), Beijing, P.R. China.
Abstract:
Primary retroperitoneal liposarcoma is generally regarded as a genetic disorder. We have retrospectively genotyped 8 single nucleotide polymorphisms (SNPs) in 6 candidate genes (MDM2, CDK4, CDC27, FPGS, IGFN1, and PRAMEF13) in 138 patients and 131 healthy control subjects to evaluate the effects of genetic factors on individual susceptibility to primary retroperitoneal liposarcoma in Chinese population. Three SNPs (rs2870820, rs1695147, rs3730536) of MDM2 showed significant differences in single-loci genotypes and allele frequencies between case and control groups (p < 0.05). The minor allele G of SNP rs10760502 in FPGS (folylpolyglutamate synthase) gene was significantly associated with increased risk for primary retroperitoneal liposarcoma, compared with major allele A. Our data suggest that FPGS variant in Chinese population may affect individual susceptibility to primary retroperitoneal liposarcoma.
More Related Videos
Related Concept Videos
Non-LTR Retrotransposons
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

